FGFR1OP2P1

Across TCGA pan-cancer cohorts, FGFR1OP2P1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated FGFR1OP2P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher FGFR1OP2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FGFR1OP2P1 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

SKCM, BLCA, and UCEC are the cancer types where FGFR1OP2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.053	0.757	<.001	54	view →
BLCA	DFS	Tertile	All	0.163	0.625	.018	45	view →
UCEC	OS	Tertile	All	0.724	0.876	.007	24	view →
STAD	DFS	Tertile	IV	1.000	0.251	.008	18	view →
UVM	OS	Tertile	All	0.249	0.712	.033	18	view →
ESCA	OS	Tertile	III,IV	0.852	0.351	.012	18	view →
LAML	DFS	Tertile	All	0.195	0.588	.041	18	view →
SARC	DFS	Tertile	All	0.148	0.594	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

FGFR1OP2P1–SKCM (DFS)

Open the SKCM breakdown →